3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Not yet recruiting
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Conditions
Brain Neoplasms
2
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Specimen Handling
57
Magnetic Resonance Spectroscopy
39
Carboplatin
32
Cyclophosphamide
29
Gemcitabine
28
Bevacizumab
24
pembrolizumab
23
Cisplatin
23
Biopsy
23
Paclitaxel
22
Standard of Care
21
Radiotherapy
21
Drug Therapy
21
fludarabine
20
Injections
20
Capecitabine
20
venetoclax
19
Oxaliplatin
19
Nivolumab
18
Interviews as Topic
17
toripalimab
16
Dexamethasone
16
Blood Specimen Collection
16
Radiosurgery
14
tislelizumab
13
cemiplimab
13
anlotinib
13
Azacitidine
13
Pemetrexed
12
Irinotecan
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Receptors, Interleukin-8B
×
90 days
×
Clear all
NCT06946680
2026-05-22
Peds IMPACT
University of Florida
Phase 1
Not yet recruiting
24 enrolled
NCT07569263
2026-05-06
IMPACT MET
University of Florida
Phase 1
Not yet recruiting
12 enrolled